Literature DB >> 22284667

Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease.

E Jauniaux1, D Jurkovic.   

Abstract

Placenta accreta refers to different grades of abnormal placental attachment to the uterine wall, which are characterised by invasion of trophoblast into the myometrium. Placenta accreta has only been described and studied by pathologists for less than a century. The fact that the first detailed description of a placenta accreta happened within a couple of decades of major changes in the caesarean surgical techniques is highly suggestive of a direct relationship between prior uterine surgery and abnormal placenta adherence. Several concepts have been proposed to explain the abnormal placentation in placenta accreta including a primary defect of the trophoblast function, a secondary basalis defect due to a failure of normal decidualization and more recently an abnormal vascularisation and tissue oxygenation of the scar area. The vast majority of placenta accreta are found in women presenting with a previous history of caesarean section and a placenta praevia. Recent epidemiological studies have also found that the strongest risk factor for placenta praevia is a prior caesarean section suggesting that a failure of decidualization in the area of a previous uterine scar can have an impact on both implantation and placentation. Ultrasound studies of uterine caesarean section scar have shown that large and deep myometrial defects are often associated with absence of re-epithelialisation of the scar area. These findings support the concept of a primary deciduo-myometrium defect in placenta accreta, exposing the myometrium and its vasculature below the junctional zone to the migrating trophoblast. The loss of this normal plane of cleavage and the excessive vascular remodelling of the radial and arcuate arteries can explain the in-vivo findings and the clinical consequence of placenta accreta. Overall these data support the concept that abnormal decidualization and trophoblastic changes of the placental bed in placenta accreta are secondary to the uterine scar and thus entirely iatrogenic. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22284667     DOI: 10.1016/j.placenta.2011.11.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  57 in total

1.  Predelivery uterine arteries embolization in patients affected by placental implant anomalies.

Authors:  Francesco Giurazza; Giuseppe Albano; Liliana Valentino; Emiliano Schena; Tiziana Capussela; Maria Antonella Di Pasquale; Francesco Di Pietto; Rosaria De Ritis; Gennaro Nasti; Giuseppe Scognamiglio; Raffaella Niola
Journal:  Radiol Med       Date:  2017-07-29       Impact factor: 3.469

Review 2.  Investigation of human trophoblast invasion in vitro.

Authors:  Yassen Abbas; Margherita Y Turco; Graham J Burton; Ashley Moffett
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

3.  Impact of placenta previa with placenta accreta spectrum disorder on fetal growth.

Authors:  E Jauniaux; I Dimitrova; N Kenyon; M Mhallem; N A Kametas; N Zosmer; C Hubinont; K H Nicolaides; S L Collins
Journal:  Ultrasound Obstet Gynecol       Date:  2019-11       Impact factor: 7.299

Review 4.  First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.

Authors:  Fengge Wang; Shuxiong Chen; Jishui Wang; Yangping Wang; Fang Ruan; Hua Shu; Liangxi Zhu; Dongmei Man
Journal:  Arch Gynecol Obstet       Date:  2021-01-30       Impact factor: 2.344

5.  Increased incidence of post-term delivery and Cesarean section after frozen-thawed embryo transfer during a hormone replacement cycle.

Authors:  Kazuki Saito; Kenji Miyado; Kenji Yamatoya; Akira Kuwahara; Eisuke Inoue; Mami Miyado; Maki Fukami; Tomonori Ishikawa; Takakazu Saito; Toshiro Kubota; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

Review 6.  Abnormal Placentation Associated with Infertility as a Marker of Overall Health.

Authors:  Lauren W Sundheimer; Margareta D Pisarska
Journal:  Semin Reprod Med       Date:  2017-06-28       Impact factor: 1.303

7.  Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomes.

Authors:  Lingling Zhu; Limei Xie
Journal:  J Med Ultrason (2001)       Date:  2019-08-07       Impact factor: 1.314

8.  Transcriptional Dynamics of Cultured Human Villous Cytotrophoblasts.

Authors:  Joshua F Robinson; Mirhan Kapidzic; Matthew Gormley; Katherine Ona; Terrence Dent; Helia Seifikar; Emily G Hamilton; Susan J Fisher
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

9.  Combined laparoscopy and hysteroscopy vs. uterine curettage in the uterine artery embolization-based management of cesarean scar pregnancy: a cohort study.

Authors:  Xin Wu; Xiaohong Xue; Xuezhe Wu; Ru Lin; Ying Yuan; Qing Wang; Congjian Xu; Yifeng He; Weiguo Hu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

10.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.